NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

China Investigates Trip.com for Alleged Monopoly Abuse Ahead of Holiday Rush

China's market regulator probes Trip.com Group for antitrust violations, accusing the dominant travel platform of abusing market power. Shares drop 6.5% as investigation unfolds.

China Investigates Trip.com for Alleged Monopoly Abuse Ahead of Holiday Rush
Credit: Qilai Shen/Bloomberg
Already have an account? Sign in.
01/14/2026 · 7:55 AM
TCOM
/ Read more

Feed↓

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
06/26/2026 · 4:53 PM

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised

The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.

/ Subscriber only
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
06/26/2026 · 3:43 PM

Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle

Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.

/ Subscriber only
BTIG Bullish on Robinhood: Launches Coverage with $125 Target, Citing Long-Term Compounding Power
06/26/2026 · 1:10 PM

BTIG Bullish on Robinhood: Launches Coverage with $125 Target, Citing Long-Term Compounding Power

BTIG is bullish on Robinhood, seeing strong growth, young users, rising trading activity, and a $125 price target.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe